GentiBio
Phase 1Our modular engineering platform allows us to create optimized Tregs phenotypes tailored to address a wide variety of autoimmune, alloimmune and inflammatory diseases.
Founded
2020
Focus
Cell & Gene Therapy
About
Our modular engineering platform allows us to create optimized Tregs phenotypes tailored to address a wide variety of autoimmune, alloimmune and inflammatory diseases.
Funding History
2Total raised: $177M
Series A$157MRA Capital ManagementSep 15, 2021
Seed$20MAtlas VentureOct 15, 2020
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile